Nexalin Technology (Nexalin Technology) EBIT per Share : $-0.81 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nexalin Technology EBIT per Share?

Nexalin Technology's EBIT per Share for the three months ended in Mar. 2024 was $-0.14. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.81.

During the past 3 years, the average EBIT per Share Growth Rate was -20.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Nexalin Technology's EBIT per Share or its related term are showing as below:

NXL' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -20 Med: -20 Max: -20
Current: -20

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Nexalin Technology was -20.00% per year. The lowest was -20.00% per year. And the median was -20.00% per year.

NXL's 3-Year EBIT Growth Rate is ranked worse than
78.54% of 727 companies
in the Medical Devices & Instruments industry
Industry Median: 5.9 vs NXL: -20.00

Nexalin Technology's EBIT for the three months ended in Mar. 2024 was $-1.07 Mil.

Nexalin Technology EBIT per Share Historical Data

The historical data trend for Nexalin Technology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexalin Technology EBIT per Share Chart

Nexalin Technology Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBIT per Share

-0.46

-1.22

-0.33

-0.77

Nexalin Technology Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial									-0.11	-0.11	-0.31	-0.25	-0.14

Nexalin Technology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Nexalin Technology's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-5.696	/	7.357
=	-0.77

Nexalin Technology's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.074	/	7.437
=	-0.14

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.81

Nexalin Technology (NAS:NXL) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Nexalin Technology EBIT per Share Related Terms

Thank you for viewing the detailed overview of Nexalin Technology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nexalin Technology (Nexalin Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexalin Technology Inc (NAS:NXL) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1776 Yorktown, Suite 550, Houston, TX, USA, 77056

Website

https://www.nexalin.com

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.

Executives

Marilyn Elson	10 percent owner, officer: Ms. Elson serves as CFO	32 CAMLET COURT, ROSELAND NJ 07068
Rick Morad	director	6331 CHAGRIN RIVER ROAD, BENTLEYVILLE OH 44022
Mark White	director, officer: President/CEO	1776 YORKTOWN STREET, SUITE 550, HOUSTON TX 77056
David Owens	director, officer: Chief Medical Officer	4545 HARRIS TRAIL NW, ATLANTA GA 30327
Alan Kazden	director	3435 CONSUELO DRIVE, CALABASAS CA 91302
Leonard Osser	other: Spouse
Ben Hu	director	7021 EDGERTON ROAD, NORTH ROYALTON OH 44133